Welcome to our dedicated page for BF SEC filings (Ticker: BF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Brown-Forman Corporation filings document formal disclosures for a public spirits company with Class A common stock, nonvoting common stock, and outstanding notes. Recent Form 8-K reports furnish operating results and financial condition updates, Regulation FD releases, and other material-event disclosures tied to the company’s beverage alcohol business.
The filing record also covers executive officer changes, compensatory arrangements, an executive change-in-control severance plan, and board authorization of share repurchases. These disclosures provide the formal record for Brown-Forman’s governance actions, capital structure, securities, and recurring public-company reporting obligations.
Brown-Forman (BF) filed a Form 4 disclosing that EVP & CFO Leanne D. Cunningham received a stock appreciation right (SAR) covering 75,105 Class B shares on 07/24/2025. The SAR carries an exercise price of $31.15, becomes exercisable on 05/01/2028, and expires on 04/30/2035. No common shares were bought or sold; the filing records only the new derivative grant. After the award, Cunningham directly holds 75,105 derivative securities and no change is reported for her non-derivative ownership. The transaction appears to be routine long-term incentive compensation and does not materially affect Brown-Forman’s share count or control structure.
On 25 Jul 2025, Brown-Forman (NYSE: BF) filed a Form 4 reporting that Yiannis Pafilis—EVP & President for Europe, Africa and Asia—received 31,317 Stock Appreciation Rights (SARs) on 24 Jul 2025. Each SAR carries a $31.15 exercise price, first becomes exercisable on 1 May 2028 and expires on 30 Apr 2035. The award was coded “A” (grant) and is held directly; no Class A or Class B common shares were bought or sold. The filing reflects routine, compensation-related equity issuance and does not indicate open-market trading by the insider.